Mode
Text Size
Log in / Sign up

Elevated maternal serum ferritin linked to higher small-for-gestational-age risk in Shanghai cohortToo Much Iron in Pregnancy May Hurt Baby’s Growth

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that elevated maternal serum ferritin may be associated with a higher risk of small-for-gestational-age birth.

This was a cohort study of 17,451 women who delivered at Shanghai First Maternity and Infant Hospital between 2018 and 2020. The study examined the association between maternal serum ferritin (SF) levels and the risk of small-for-gestational-age (SGA) birth.

Women with elevated SF (≥18.1 ng/mL) had a significantly higher incidence of SGA at 29.0–31.6 weeks of gestation compared to those with lower levels (4.4% vs. 2.4%). The adjusted odds ratio (aOR) was 1.418 (95% CI: 1.089–1.846, P = 0.009). A significant positive dose-response relationship was observed (P for trend < 0.0001).

The risk of SGA was also significantly increased in women with medium first-trimester SF and high third-trimester SF compared to consistently low SF (aOR = 1.712, 95% CI: 1.138–2.576, P = 0.01), and in women with high SF in both trimesters (aOR = 1.676, 95% CI: 1.118–2.513, P = 0.012). However, SF dropping from high to medium between trimesters was not associated with increased SGA risk (aOR = 0.951, 95% CI: 0.614–1.472).

Safety and tolerability data were not reported. The study's observational design means causality cannot be inferred, and follow-up duration was not reported. These results challenge the current practice of routine iron supplementation in pregnant women with normal iron levels, but the findings require confirmation in randomized trials.

A Surprising Finding

Imagine you are pregnant. Your doctor tells you to take iron pills to stay healthy and help your baby grow. You take them every day. But what if taking too much iron could actually work against you?

A new study from Shanghai suggests that high iron levels in the third trimester might be linked to smaller babies. This finding challenges what many doctors have believed for years.

Small-for-gestational-age (SGA) means a baby is smaller than expected for their gestational age. This can happen for many reasons. It can lead to health issues for the baby, both at birth and later in life.

About 1 in 10 babies worldwide are born SGA. It is a major concern for doctors and parents.

Current guidelines often recommend iron supplements for all pregnant women. The goal is to prevent anemia (low iron). But this study asks a key question: Is more iron always better?

The Old Way vs. The New Way

For a long time, the thinking has been simple. Iron helps make blood. More iron is better for the growing baby.

Doctors often check for anemia. If iron is low, they prescribe supplements. If iron is normal, they still might suggest a daily pill.

But here’s the twist. This study found that having too much iron in the blood might be a problem. It suggests that "normal" iron levels might not be the same as "optimal" iron levels for every woman.

Think of iron in your body like water in a bathtub. You need enough to fill it, but you don’t want it to overflow.

Iron is essential for making hemoglobin, the part of red blood cells that carries oxygen. Your baby needs this oxygen to grow.

But iron also acts as a fertilizer for cells. In the right amount, it helps cells grow. In too high an amount, it might cause stress on the body’s systems. This stress could potentially affect how the placenta works or how the baby develops.

The study looked at ferritin. This is a protein that stores iron in your blood. It’s like a battery for your body’s iron supply.

Researchers in Shanghai looked at the medical records of over 17,000 pregnant women. They delivered at one hospital between 2018 and 2020.

The doctors measured the women’s iron stores (serum ferritin) twice during pregnancy. Once in the first trimester (around 8–14 weeks) and once in the third trimester (around 29–32 weeks).

They tracked who had smaller babies (SGA) and compared that to the mother’s iron levels.

The results were clear. High iron levels in the third trimester were linked to a higher risk of having a smaller baby.

Women with the highest iron levels (top 25%) had a 41% higher chance of having an SGA baby compared to those with lower levels. About 4.4% of women with high iron had smaller babies, versus 2.4% with lower iron.

The risk went up as iron levels went up. This is called a dose-response relationship. It means more iron meant more risk, up to a point.

The timing mattered too. Women who had high iron in both the first and third trimesters had a 68% higher risk. But if a woman started with high iron and then dropped to a medium level, her risk did not increase.

This suggests that high iron late in pregnancy is the key factor.

But There’s a Catch

This does not mean you should stop taking your prenatal vitamins. The study looked at women with normal iron levels, not those who were anemic.

This doesn’t mean this treatment is available yet.

The study shows a link, not a direct cause. It’s possible that other factors are at play. For example, women with high iron might have other health issues that affect baby growth.

This study challenges the "more is better" approach to iron in pregnancy. It suggests that doctors might need to be more careful about who gets iron supplements.

The researchers conclude that routine iron supplementation for women with normal iron levels might need a second look. This is a shift from current practice in many places.

If you are pregnant, do not stop taking your iron pills without talking to your doctor. This study is one piece of a larger puzzle.

The best advice is to have your iron levels checked regularly. This includes ferritin, not just hemoglobin. Talk to your doctor about what your numbers mean for you.

Every pregnancy is unique. Your doctor can help you decide the right amount of iron for your specific needs.

This study has some important limits. It was done in one hospital in Shanghai. The results might be different for women in other parts of the world.

It is also an observational study. This means it found a link but cannot prove that high iron causes smaller babies. Other factors, like diet or genetics, could be involved.

The study did not track whether women were taking iron pills. It only measured the iron in their blood.

More research is needed. Scientists need to study this in different populations. They also need to test if lowering iron doses for women with normal levels actually leads to healthier babies.

For now, this study adds an important question to the conversation about prenatal care. It reminds us that sometimes, even good things can be too much.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundIron supplementation is essential for maintaining maternal-fetal health during pregnancy. However, research on the relationship between serum ferritin (SF) and small-for-gestational-age (SGA) births remains limited and inconclusive.ObjectiveThis study aimed to investigate the association between maternal SF levels and SGA during pregnancy.MethodsWe utilized electronic medical records from women who delivered at Shanghai First Maternity and Infant Hospital between 2018 and 2020. Maternal SF levels were measured at 8.0–13.6 weeks' gestation (GW) and 29.0–31.6 GW. Based on these measurements, participants were categorized into three groups according to SF concentration percentiles: low (< 25th), medium (25th to < 75th), and high (≥75th). The association between maternal SF levels and SGA was evaluated using binary logistic regression. Additionally, a restricted cubic spline model was employed to explore potential nonlinear relationships between SF levels and the risk of SGA.ResultsA total of 17,451 pregnant women were included. At 29.0–31.6 weeks of gestation, women with elevated serum ferritin (SF) (≥18.1 ng/mL, ≥75th percentile) had a significantly higher incidence of SGA than those with lower levels [4.4% vs. 2.4%; adjusted odds ratio (aOR) = 1.418, 95% CI: 1.089–1.846, P = 0.009]. A significant positive dose-response relationship between SF levels and SGA risk was observed (P for trend < 0.0001), with a threshold of 12.1 ng/ml. Compared with women with consistently low SF levels in both trimesters, the risk of SGA was significantly increased in two groups: 1) those with medium first-trimester SF (31.5 to < 81.9 ng/ml) and high third-trimester SF (≥18.1 ng/ml) (aOR = 1.712, 95% CI: 1.138–2.576, P = 0.01); and 2) those with high SF in both trimesters (first: ≥81.9 ng/ml; third: ≥18.1 ng/ml) (aOR = 1.676, 95% CI: 1.118–2.513, P = 0.012). However, SF levels dropping from high to medium between trimesters was not associated with an increased risk of SGA (aOR = 0.951, 95% CI: 0.614–1.472).ConclusionsOur findings demonstrate an independent and positive association between elevated maternal serum ferritin levels during the third trimester of pregnancy and increased risk of SGA. These results challenge the current practice of routine iron supplementation in pregnant women with normal iron levels.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.